PIIIW Begin Period Cash Flow from 2010 to 2024

PIIIW Stock  USD 0.01  0  11.88%   
P3 Health Begin Period Cash Flow yearly trend continues to be fairly stable with very little volatility. Begin Period Cash Flow will likely drop to about 17.4 M in 2024. Begin Period Cash Flow is the amount of cash P3 Health Partners has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. View All Fundamentals
 
Begin Period Cash Flow  
First Reported
2010-12-31
Previous Quarter
18.5 M
Current Value
17.4 M
Quarterly Volatility
12.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check P3 Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among P3 Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 91 M, Interest Expense of 15.2 M or Selling General Administrative of 116.2 M, as well as many indicators such as Price To Sales Ratio of 0.0932, Dividend Yield of 0.0 or PTB Ratio of 0.83. PIIIW financial statements analysis is a perfect complement when working with P3 Health Valuation or Volatility modules.
  
Check out the analysis of P3 Health Correlation against competitors.

Latest P3 Health's Begin Period Cash Flow Growth Pattern

Below is the plot of the Begin Period Cash Flow of P3 Health Partners over the last few years. It is the amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. P3 Health's Begin Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in P3 Health's overall financial position and show how it may be relating to other accounts over time.
Begin Period Cash Flow10 Years Trend
Slightly volatile
   Begin Period Cash Flow   
       Timeline  

PIIIW Begin Period Cash Flow Regression Statistics

Arithmetic Mean8,556,339
Geometric Mean3,242,899
Coefficient Of Variation148.44
Mean Deviation9,923,758
Median2,013,579
Standard Deviation12,700,929
Sample Variance161.3T
Range39.8M
R-Value0.55
Mean Square Error120.5T
R-Squared0.31
Significance0.03
Slope1,571,372
Total Sum of Squares2258.4T

PIIIW Begin Period Cash Flow History

202417.4 M
202318.5 M
2022140.8 K
202139.9 M
202032.9 M
20191.4 M

About P3 Health Financial Statements

P3 Health investors use historical fundamental indicators, such as P3 Health's Begin Period Cash Flow, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in P3 Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Begin Period Cash Flow18.5 M17.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for PIIIW Stock Analysis

When running P3 Health's price analysis, check to measure P3 Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy P3 Health is operating at the current time. Most of P3 Health's value examination focuses on studying past and present price action to predict the probability of P3 Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move P3 Health's price. Additionally, you may evaluate how the addition of P3 Health to your portfolios can decrease your overall portfolio volatility.